Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.45 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | ADH1B | P00325 | 1/20 | 0.38 |
| ▸ | ADH1C | P00326 | 1/20 | 0.38 |
| ▸ | ADH1A | P07327 | 1/20 | 0.38 |
| ▸ | ADH4 | P08319 | 1/20 | 0.38 |
| ▸ | ADH7 | P40394 | 1/20 | 0.38 |
| ▸ | GMNN | O75496 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | THPO | P40225 | 1/20 | 0.38 |
| ▸ | MTOR | P42345 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30117301 | 0.98 | OPRM1 (0.44) | SPHK1OPRM1LMNADNM1CYP2D6 | |
| SCHEMBL8603359 | 0.90 | — | — | |
| SCHEMBL29647839 | 0.87 | OPRM1 (0.48) | SPHK1OPRM1LMNADNM1TSHR | |
| SCHEMBL16782308 | 0.87 | OPRM1 (0.48) | SPHK1OPRM1LMNADNM1TSHR | |
| SCHEMBL1694745 | 0.80 | SPHK1 (0.48) | SPHK1OPRM1LMNADNM1TSHR | |
| SCHEMBL1694200 | 0.80 | SPHK1 (0.48) | SPHK1OPRM1LMNADNM1TSHR | |
| SCHEMBL30368458 | 0.79 | — | — | |
| SCHEMBL5561973 | 0.79 | — | — | |
| SCHEMBL5068321 | 0.79 | SPHK1 (0.43) | SPHK1OPRM1LMNAADH1BADH1C | |
| SCHEMBL21218968 | 0.79 | SPHK1 (0.43) | SPHK1OPRM1LMNAADH1BADH1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100215603-A1 | Body Surface Protecting Composition | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2010-08-26 | — | — | US | disclosed |
| EP-1891924-A1 | COMPOSITION FOR PROTECTION OF BODY SURFACE | Asahi Kasei Chemicals Corporation (JP) | 2008-02-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100215603-A1 | Body Surface Protecting Composition | FABP2, CUTA, FABP1 | SPHK1 3318/4885OPRM1 2061/4885LMNA 445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.